Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Natural and Adaptive Immune Cell-Based Therapies in Autoimmunity

Author(s): Antonio L. Cava and Fu-Dong Shi

Volume 13, Issue 13, 2006

Page: [1557 - 1566] Pages: 10

DOI: 10.2174/092986706777442020

Price: $65

Abstract

Recent studies have raised great interest in the modulation of autoimmune responses by manipulation of immunoregulatory cells. Several lymphocyte subpopulations responsible for the induction and maintenance of immune tolerance have been extensively studied, and much has been learned about their properties. Lately, a series of attempts to harness the immunoregulatory activities of these cells for therapeutic purposes has proven successful in preclinical studies. The development of new strategies for the expansion of glycolipid-induced activation of NKT cells and antigenspecific regulatory T cells represent examples that have generated considerable interest and that are leading to the development of immunoregulatory cell-based approaches translating the findings from the bench to the bedside. This review highlights the advances, obstacles and limitations of these studies and critically discusses the most recent findings in this rapidly expanding field.

Keywords: autoimmune diseases, natural killer T (NKT) cells, lipopolysaccharide (LPS), Immunoregulatory Cells, nonobese diabetic (NOD), Foxp3-deficient mice


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy